We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMED
726
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$284K ﹤0.01%
380,000
– –
ARAY icon
727
Accuray
ARAY
$28.4M
$283K ﹤0.01%
82,853
+12,853
+18% +$52.1K
VOYA icon
728
Voya Financial
VOYA
$8.94B
$283K ﹤0.01%
7,044
+1,341
+24% +$59.6K
EEM icon
729
iShares MSCI Emerging Markets ETF
EEM
$28B
$277K ﹤0.01%
+7,082
New +$284K
FNV icon
730
Franco-Nevada
FNV
$41.4B
$271K ﹤0.01%
3,870
– –
IBRX icon
731
ImmunityBio
IBRX
$7.44B
$270K ﹤0.01%
+232,400
New +$532K
AMG icon
732
Affiliated Managers Group
AMG
$9.46B
$263K ﹤0.01%
2,700
+1,206
+81% +$136K
QSR icon
733
Restaurant Brands International
QSR
$25.1B
$245K ﹤0.01%
4,688
– –
TOL icon
734
Toll Brothers
TOL
$14B
$244K ﹤0.01%
7,424
-20,001
-73% -$643K
POWI icon
735
Power Integrations
POWI
$3.54B
$242K ﹤0.01%
7,924
– –
SLG icon
736
SL Green Realty
SLG
$3.88B
$242K ﹤0.01%
3,162
+740
+31% +$65.5K
CIB icon
737
Grupo Cibest SA
CIB
$20.4B
$241K ﹤0.01%
+6,314
New +$252K
CVE icon
738
Cenovus Energy
CVE
$54.6B
$232K ﹤0.01%
33,012
– –
ROL icon
739
Rollins
ROL
$18.6B
$216K ﹤0.01%
+8,991
New +$232K
CIG icon
740
CEMIG Preferred Shares
CIG
$6.09B
$215K ﹤0.01%
+118,289
New +$179K
HE icon
741
Hawaiian Electric Industries
HE
$2.33B
$203K ﹤0.01%
+5,544
New +$206K
MXIM
742
DELISTED
Maxim Integrated Products
MXIM
$201K ﹤0.01%
3,952
-7,517
-66% -$392K
IBN icon
743
ICICI Bank
IBN
$106B
$198K ﹤0.01%
19,250
-15,000
-44% -$142K
AMX icon
744
America Movil
AMX
$78.1B
$193K ﹤0.01%
13,570
– –
LTM
745
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$174K ﹤0.01%
+16,880
New +$163K
AVDL
746
DELISTED
Avadel Pharmaceuticals
AVDL
$160K ﹤0.01%
62,000
– –
ABEV icon
747
Ambev
ABEV
$47.3B
$152K ﹤0.01%
38,730
– –
EXK
748
Endeavour Silver
EXK
$2.32B
$107K ﹤0.01%
+50,000
New +$105K
ELGX
749
DELISTED
Endologix Inc
ELGX
$100K ﹤0.01%
14,000
-8,000
-36% -$89.1K
GFI icon
750
Gold Fields
GFI
$29.2B
$78K ﹤0.01%
+22,122
New +$65.3K
28 29
30
31 32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.